Pharmaceuticals company Unichem Laboratories announced Q2FY27 results Consolidated Financial Highlights: Revenue from operations: For Q2FY27, consolidated revenue from operations stood at Rs 640.22 crore, registering a growth of 1.20% QoQ from Rs 632.62 crore in Q1FY27 and an increase of 10.58% YoY against Rs 578.96 crore in Q2FY26. For H1FY27, revenue reached Rs 1,272.84 crore, marking a growth of 15.13% YoY compared to Rs 1,105.56 crore in H1FY26. Total income: In Q2FY27, consolidated total income was Rs 655.59 crore, up 1.14% QoQ from Rs 648.23 crore in Q1FY27 and up 9.28% YoY from Rs 599.93 crore in Q2FY26. For H1FY27, total income reached Rs 1,303.82 crore, up 15.04% YoY over Rs 1,133.35 crore in H1FY26. Profit Before Tax (PBT): For Q2FY27, consolidated PBT recorded at Rs 27.37 crore, indicating a decrease of 44.13% QoQ from Rs 48.99 crore in Q1FY27 but showing a significant reversal from a consolidated loss before tax of Rs 10.82 crore in Q2FY26. For H1FY27, consolidated PBT came in at Rs 76.36 crore, showing a complete turnaround from a loss before tax of Rs 19.84 crore in H1FY26. Profit After Tax (PAT): In Q2FY27, consolidated profit for the period after tax stood at Rs 22.22 crore, marking a decline of 46.42% QoQ against Rs 41.47 crore in Q1FY27 and demonstrating a full recovery from a net loss of Rs 11.89 crore in Q2FY26. For H1FY27, consolidated PAT stood at Rs 63.69 crore, reversing from a net loss of Rs 22.36 crore in H1FY26. Earnings Per Share (EPS): Consolidated basic EPS for Q2FY27 was Rs 3.16, dropping 46.35% QoQ from Rs 5.89 in Q1FY27 and reversing from a negative basic EPS of Rs 1.69 in Q2FY26. For H1FY27, basic EPS reached Rs 9.05, a recovery from a loss per share of Rs 3.18 in H1FY26. Standalone Financial Highlights: Revenue from operations: Standalone revenue from operations for Q2FY27 recorded at Rs 401.90 crore, displaying an expansion of 9.73% QoQ from Rs 366.27 crore in Q1FY27 and an increase of 12.61% YoY over Rs 356.90 crore in Q2FY26. For H1FY27, standalone revenue reached Rs 768.17 crore, growing 3.65% YoY compared to Rs 741.15 crore in H1FY26. Total income: For Q2FY27, standalone total income reached Rs 418.75 crore, gaining 9.34% QoQ from Rs 382.99 crore in Q1FY27 and growing 10.69% YoY over Rs 378.30 crore in Q2FY26. For H1FY27, standalone total income stood at Rs 801.74 crore, representing a growth of 4.56% YoY from Rs 766.80 crore in H1FY26. Profit Before Tax (PBT): For Q2FY27, standalone PBT was Rs 2.03 crore, down 72.49% QoQ from Rs 7.38 crore in Q1FY27 and turning around from a standalone loss before tax of Rs 37.83 crore in Q2FY26. For H1FY27, standalone PBT reached Rs 9.41 crore, showing a reversal from a loss before tax of Rs 39.70 crore in H1FY26. Profit After Tax (PAT): Standalone profit for the period after tax stood at Rs 1.49 crore for Q2FY27, which is a reduction of 73.06% QoQ from Rs 5.53 crore in Q1FY27 and a recovery from a standalone net loss of Rs 39.93 crore in Q2FY26. For H1FY27, standalone PAT reached Rs 7.02 crore, recovering from a standalone net loss of Rs 41.78 crore in H1FY26. Earnings Per Share (EPS): Standalone basic EPS for Q2FY27 registered at Rs 0.21, reflecting a drop of 73.42% QoQ from Rs 0.79 in Q1FY27 and reversing from a loss per share of Rs 5.67 in Q2FY26. For H1FY27, standalone basic EPS was Rs 1.00, moving out of negative territory from a negative EPS of Rs 5.93 in H1FY26. Result PDF